Indications -- Psoriasis/Chronic Inflammation

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation

An SI Board Since February 2001

Posts	SubjectMarks	Bans
631	42	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
56	That's why I have been talking "dose, dose, dose" for 2-3 frigging	scaram(o)uche	-	6/7/2001
55	Elliot Lebowitz indicated today that dosing levels for current MEDI psoriasis tr	Mark Bong	-	6/7/2001
54	George, you are wasting your time. As you know the performance of Xoma lately h	Bluegreen	-	6/3/2001
53	That sort of commentary -- with analysis -- is MORE than welcome. Just want a v	scaram(o)uche	-	6/2/2001
52	Getting confused, as you said " Let's limit discussion to stuff that ad	aknahow	-	6/2/2001
51	"and it comes back worse." Rick, I read the article this morning, and	Mark Bong	-	6/2/2001
50	Xanelim and Amevive are not cures for psoriasis, as you know better than I. Am	aknahow	-	6/2/2001
49	Again, I have no bias. I would not take an agent that is progressively depletin	scaram(o)uche	-	6/2/2001
48	Did not see more than standard hedging, in the release of information. Xanelim	aknahow	-	6/2/2001
47	Thanks, George and Pierre. Let's limit discussion to stuff that addresses d	scaram(o)uche	-	6/2/2001
46	Seemed more in favor of BGEN drug than the DNA/XOMA drug	Pierre Borczuk	-	6/2/2001
45	Will do, thanks. Any comments on what was said? Assume this is in the Monday&#	aknahow	-	6/2/2001
44	Also check out the fairly lengthy article in barrons on psoriasis drugs, featuri	Pierre Borczuk	-	6/2/2001
43	For slides dealing with Xanelim, and psoriasis, check out the XOMA slide present	aknahow	-	6/2/2001
42	[ anti-CD11a, GNE (aka DNA) and XOMA ] No details (and some adverse events that	scaram(o)uche	-	5/24/2001
41	Of tangential interest - Message 15777322	nigel bates	-	5/9/2001
40	George: I recently posted (in the valuation thread?) that I was afraid of a &qu	scaram(o)uche	-	5/7/2001
39	anyone know of a psoriasis clinical trial where subjects are pre treated with st	aknahow	-	5/2/2001
38	Protein Design Labs Announces Development of SMART(TM) Anti-IL-12 Antibody FREM	nigel bates	-	5/2/2001
37	[ oral p38 kinase inhibitor ] Monday April 30, 5:30 pm Eastern Time Press Rele	scaram(o)uche	-	4/30/2001
36	Lab Invest 2001 Mar;81(3):335-47 Potential role of the c	scaram(o)uche	-	4/22/2001
35	Mark your calendars. Results for PI/II Medi-507 later this year. MedImmune als	keokalani'nui	-	4/17/2001
34	Alzheimer's........ Message 15627385	scaram(o)uche	-	4/6/2001
33	Celgene Corporation Expands Intellectual Property Estate For Important Kinases	sim1	-	4/2/2001
32	Thursday March 8, 6:30 am Eastern Time Press Release SOURCE: Genmab A/S Genma	scaram(o)uche	-	3/8/2001

Go to reply# or date (mm/dd/yy):